HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease.

AbstractBACKGROUND & AIMS:
N-linked glycosylation of proteins is critical for proper protein folding and trafficking to the plasma membrane. Drug transporters are one class of proteins that have reduced function when glycosylation is impaired. N-linked glycosylation of plasma proteins has also been investigated as a biomarker for several liver diseases, including non-alcoholic fatty liver disease (NAFLD). The purpose of this study was to assess the transcriptomic expression of genes involved in protein processing and glycosylation, and to determine the glycosylation status of key drug transporters during human NAFLD progression.
METHODS:
Human liver samples diagnosed as healthy, steatosis, and non-alcoholic steatohepatitis (NASH) were analysed for gene expression of glycosylation-related genes and for protein glycosylation using immunoblot.
RESULTS:
Genes involved in protein processing in the ER and biosynthesis of N-glycans were significantly enriched for down-regulation in NAFLD progression. Included in the down regulated N-glycan biosynthesis category were genes involved in the oligosaccharyltransferase complex, N-glycan quality control, N-glycan precursor biosynthesis, N-glycan trimming to the core, and N-glycan extension from the core. N-glycan degradation genes were unaltered in the progression to NASH. Immunoblot analysis of the uptake transporters organic anion transporting polypeptide-1B1 (OATP1B1), OATP1B3, OATP2B1, and Sodium/Taurocholate Co-transporting Polypeptide (NTCP) and the efflux transporter multidrug resistance-associated protein 2 (MRP2) demonstrated a significant loss of glycosylation following the progression to NASH.
CONCLUSIONS:
These data suggest that the loss of glycosylation of key uptake and efflux transporters in humans NASH may influence transporter function and contribute to altered drug disposition observed in NASH.
AuthorsJohn D Clarke, Petr Novak, April D Lake, Rhiannon N Hardwick, Nathan J Cherrington
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 37 Issue 7 Pg. 1074-1081 (07 2017) ISSN: 1478-3231 [Electronic] United States
PMID28097795 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Membrane Transport Proteins
Topics
  • Biological Transport
  • Blotting, Western
  • Case-Control Studies
  • Endoplasmic Reticulum (metabolism)
  • Gene Expression Profiling
  • Glycosylation
  • Humans
  • Liver (metabolism)
  • Membrane Transport Proteins (genetics, metabolism)
  • Non-alcoholic Fatty Liver Disease (diagnosis, genetics, metabolism)
  • Protein Processing, Post-Translational
  • Transcriptome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: